中国继续医学教育
中國繼續醫學教育
중국계속의학교육
CHINA CONTINUING MEDICAL EDUCATION
2015年
2期
157-158
,共2页
泌尿系统肿瘤%培美曲塞单药全身化疗%局部放疗%临床疗效
泌尿繫統腫瘤%培美麯塞單藥全身化療%跼部放療%臨床療效
비뇨계통종류%배미곡새단약전신화료%국부방료%림상료효
Urologic neoplasms%Pemetrexed single agent chemotherapy%Local radiotherapy%Clinical effect
目的:探析培美曲塞单药全身化疗加局部放疗治疗老年晚期进展期泌尿系统肿瘤的临床疗效。方法选取在我院接受治疗的20例老年晚期进展期泌尿系统肿瘤为研究对象,给予患者实施培美曲塞单药全身化疗加局部放疗进行治疗,观察患者的治疗效果和不良反应。结果所有患者的总有效率为55.0%,中位进展时间为9.5个月,中位生存期为16个月;不良反应主要为骨髓抑制、皮肤黏膜炎和胃肠道反应。结论培美曲塞单药全身化疗加局部放疗治疗老年晚期进展期泌尿系统肿瘤可以延长患者生存期,提高患者的生活质量,不良反应可耐受,值得临床推广应用。
目的:探析培美麯塞單藥全身化療加跼部放療治療老年晚期進展期泌尿繫統腫瘤的臨床療效。方法選取在我院接受治療的20例老年晚期進展期泌尿繫統腫瘤為研究對象,給予患者實施培美麯塞單藥全身化療加跼部放療進行治療,觀察患者的治療效果和不良反應。結果所有患者的總有效率為55.0%,中位進展時間為9.5箇月,中位生存期為16箇月;不良反應主要為骨髓抑製、皮膚黏膜炎和胃腸道反應。結論培美麯塞單藥全身化療加跼部放療治療老年晚期進展期泌尿繫統腫瘤可以延長患者生存期,提高患者的生活質量,不良反應可耐受,值得臨床推廣應用。
목적:탐석배미곡새단약전신화료가국부방료치료노년만기진전기비뇨계통종류적림상료효。방법선취재아원접수치료적20례노년만기진전기비뇨계통종류위연구대상,급여환자실시배미곡새단약전신화료가국부방료진행치료,관찰환자적치료효과화불량반응。결과소유환자적총유효솔위55.0%,중위진전시간위9.5개월,중위생존기위16개월;불량반응주요위골수억제、피부점막염화위장도반응。결론배미곡새단약전신화료가국부방료치료노년만기진전기비뇨계통종류가이연장환자생존기,제고환자적생활질량,불량반응가내수,치득림상추엄응용。
Objective To probe into the clinical curative effect of pemetrexed single agent chemotherapy combined with local radiotherapy for elderly patients with advanced tumor in urinary system. Methods Select 20 cases of elderly patients with advanced treated in our hospital during the progression of tumors of urinary system as the research object, to give patients with pemetrexed single agent chemotherapy and local radiotherapy treatment, to observe the therapeutic effect and adverse reaction of patients. Results All patients with the total effective rate was 40.0%, the median progress time is 7.5 months, the median survival period for 14 months. Adverse reactions mainly in bone marrow suppression and gastrointestinal reaction. Conclusion Pemetrexed single agent chemotherapy and local radiotherapy treatment can prolong the survival of elderly patients with advanced tumors of urinary system, adverse reactions can be tolerated, improve the quality of life of patients, is worthy of clinical application.